BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26917345)

  • 41. Application of next-generation sequencing to detect acyclovir-resistant herpes simplex virus type 1 variants at low frequency in thymidine kinase gene of the isolates recovered from patients with hematopoietic stem cell transplantation.
    Fujii H; Kakiuchi S; Tsuji M; Nishimura H; Yoshikawa T; Yamada S; Omura N; Inagaki T; Shibamura M; Harada S; Taniguchi S; Saijo M
    J Virol Methods; 2018 Jan; 251():123-128. PubMed ID: 29074089
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
    Shiota T; Lixin W; Takayama-Ito M; Iizuka I; Ogata M; Tsuji M; Nishimura H; Taniguchi S; Morikawa S; Kurane I; Mizuguchi M; Saijo M
    Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
    Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
    J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomised placebo-controlled trial to explore the effect of suppressive therapy with acyclovir on genital shedding of HIV-1 and herpes simplex virus type 2 among Zimbabwean sex workers.
    Cowan FM; Pascoe SJ; Barlow KL; Langhaug LF; Jaffar S; Hargrove JW; Robinson NJ; Bassett MT; Wilson D; Brown DW; Hayes RJ
    Sex Transm Infect; 2008 Dec; 84(7):548-53. PubMed ID: 18684855
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduction of herpes simplex virus type-2 replication in cell cultures and in rodent models with peptide-conjugated morpholino oligomers.
    Eide K; Moerdyk-Schauwecker M; Stein DA; Bildfell R; Koelle DM; Jin L
    Antivir Ther; 2010; 15(8):1141-9. PubMed ID: 21149921
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
    Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Testing of herpes simplex virus for resistance to antiviral drugs.
    Sauerbrei A; Deinhardt S; Zell R; Wutzler P
    Virulence; 2010; 1(6):555-7. PubMed ID: 21178503
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Latent acyclovir-resistant herpes simplex virus type 1 in trigeminal ganglia of immunocompetent individuals.
    van Velzen M; van Loenen FB; Meesters RJ; de Graaf M; Remeijer L; Luider TM; Osterhaus AD; Verjans GM
    J Infect Dis; 2012 May; 205(10):1539-43. PubMed ID: 22457282
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of a novel mutation conferring acyclovir resistance and consecutive treatment failure in an HIV-positive patient with recurrent HSV-2 infection.
    Schleenvoigt BT; Pletz MW; Deinhardt-Emmer S; Sauerbrei A
    J Glob Antimicrob Resist; 2018 Mar; 12():20. PubMed ID: 29179992
    [No Abstract]   [Full Text] [Related]  

  • 50. Acyclovir-resistant HSV-1 isolates among immunocompromised patients in southern Taiwan: Low prevalence and novel mutations.
    Kuo JY; Yeh CS; Wang SM; Chen SH; Wang JR; Chen TY; Tsai HP
    J Med Virol; 2023 Aug; 95(8):e28985. PubMed ID: 37505438
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics.
    Reyes M; Shaik NS; Graber JM; Nisenbaum R; Wetherall NT; Fukuda K; Reeves WC;
    Arch Intern Med; 2003 Jan; 163(1):76-80. PubMed ID: 12523920
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of an acyclovir-resistant herpes simplex virus type 2 strain isolated from a premature neonate.
    Oram RJ; Marcellino D; Strauss D; Gustafson E; Talarico CL; Root AK; Sharma PL; Thompson K; Fingeroth JD; Crumpacker C; Herold BC
    J Infect Dis; 2000 Apr; 181(4):1458-61. PubMed ID: 10762577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir.
    Wald A; Zeh J; Barnum G; Davis LG; Corey L
    Ann Intern Med; 1996 Jan; 124(1 Pt 1):8-15. PubMed ID: 7503497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial.
    Fuchs J; Celum C; Wang J; Hughes J; Sanchez J; Cowan F; Reid S; Delany-Moretlwe S; Corey L; Wald A;
    J Infect Dis; 2010 Apr; 201(8):1164-8. PubMed ID: 20214474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Self-collected genital swabs compared with cervicovaginal lavage for measuring HIV-1 and HSV-2 and the effect of acyclovir on viral shedding.
    McNicholl JM; Leelawiwat W; Whitehead S; Hanson DL; Evans-Strickfaden T; Cheng CY; Chonwattana W; Mueanpai F; Kittinunvorakoon C; Markowitz L; Dunne EF
    Int J STD AIDS; 2017 Mar; 28(4):372-379. PubMed ID: 27179350
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A point mutation in the thymidine kinase gene is responsible for acyclovir-resistance in herpes simplex virus type 2 sequential isolates.
    Palù G; Gerna G; Bevilacqua F; Marcello A
    Virus Res; 1992 Sep; 25(1-2):133-44. PubMed ID: 1329374
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dendritic keratitis caused by an acyclovir-resistant herpes simplex virus with frameshift mutation.
    Zhang W; Suzuki T; Shiraishi A; Shimamura I; Inoue Y; Ohashi Y
    Cornea; 2007 Jan; 26(1):105-6. PubMed ID: 17198024
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis.
    Burrel S; Boutolleau D; Azar G; Doan S; Deback C; Cochereau I; Agut H; Gabison EE
    J Clin Virol; 2013 Sep; 58(1):321-4. PubMed ID: 23731845
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recurrent antiviral-resistant genital herpes in an immunocompetent patient.
    Kriesel JD; Spruance SL; Prichard M; Parker JN; Kern ER
    J Infect Dis; 2005 Jul; 192(1):156-61. PubMed ID: 15942905
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acyclovir susceptibility of herpes simplex virus isolates at King Chulalongkorn Memorial Hospital, Bangkok.
    Sangdara A; Bhattarakosol P
    J Med Assoc Thai; 2008 Jun; 91(6):908-12. PubMed ID: 18697392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.